Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
株式のランク #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
株価
$1.04
時価総額
$603.62M
変化(1日)
-2.52%
変化(1年)
-38.05%
CN
取引 MicroPort NeuroTech Limited (2172)

カテゴリー

MicroPort NeuroTech Limited(2172)の株式分割履歴
MicroPort NeuroTech Limited株(シンボル:2172)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 31, 2026に行われました。
Aug 31, 2026より前に購入された2172株は、現在02172株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE